Celebrex Generics Will Wait For December; Teva Exclusivity “Reasonable,” Court Finds
This article was originally published in The Pink Sheet Daily
Executive Summary
Mylan denied preliminary injunction as judge affirms FDA’s position that original and reissued patents are single bundle.